Elevance Health, Inc.

ELV
As of the close on Sep 25, 2026
Price
$396.09
Market cap
$85.9B
P/E (diluted TTM)
17.5
EPS (TTM)
$22.59
Four quarters to Jun 30, 2026
Dividend yield
—
Dividend records do not yet cover the latest payments

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How Elevance Health, Inc. Makes Money

Follow each dollar of revenue through to what shareholders keep.

From revenue to net income

Pick a year or quarter. Each band's width is its dollar amount.

Source: Elevance Health, Inc. — 10-Q filed Jul 15, 2026

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 19 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 15, 2026.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Unusually large insider trades

Each trade is compared with the other insider trades of the same kind in the same security among Elevance Health, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.

  • 2024-10-18 · Kendrick Charles Morgan JR: Larger than 34 of the 37 other insider sales of Common Stock on file. SEC filing
  • 2024-07-22 · BOUDREAUX GAIL: Larger than all 37 other insider sales of Common Stock on file. SEC filing
  • 2024-04-23 · Norwood Felicia F: Larger than 35 of the 37 other insider sales of Common Stock on file. SEC filing
  • 2024-03-04 · Haytaian Peter D: Larger than 36 of the 37 other insider sales of Common Stock on file. SEC filing

Purchases & sales (open market or private)

SecurityCodePriceFiling
2026-06-12Penczek Ronald W · CAO & ControllerCommon StockS — Open market or private sale−369403.16SEC filing
2026-06-11Dixon Robert L JR · DirectorCommon StockS — Open market or private sale−151401.77SEC filing
2026-05-19Penczek Ronald W · CAO & ControllerCommon StockS — Open market or private sale−1,531403.13SEC filing
2026-03-12SCHULMAN AMY W · DirectorCommon StockS — Open market or private sale−26287.50SEC filing
2026-03-06Kendrick Charles Morgan JR · EVP & President, CommercialCommon StockS — Open market or private sale−3,196284.92SEC filing
2026-03-05COLLIS STEVEN H · DirectorCommon StockP — Open market or private purchase+3,000289.84SEC filing
2025-08-19DeVore Susan D. · DirectorCommon StockP — Open market or private purchase+1,200312.15SEC filing
2025-07-18BOUDREAUX GAIL · President and CEOCommon StockP — Open market or private purchase+5,116287.12SEC filing

Showing 8 of 15 rows

Grants, exercises, tax & gifts

SecurityCodeFiling
2026-05-19Penczek Ronald W · CAO & ControllerEmployee Stock Option (Right to Buy)M — Exercise or conversion of derivative security−654SEC filing
2026-05-19Penczek Ronald W · CAO & ControllerEmployee Stock Option (Right to Buy)M — Exercise or conversion of derivative security−877SEC filing
2026-05-19Penczek Ronald W · CAO & ControllerCommon StockM — Exercise or conversion of derivative security+877SEC filing
2026-05-19Penczek Ronald W · CAO & ControllerCommon StockM — Exercise or conversion of derivative security+654SEC filing
2026-05-13Dixon Robert L JR · DirectorCommon StockA — Grant, award, or other acquisition+563SEC filing
2026-05-13DeVore Susan D. · DirectorCommon StockA — Grant, award, or other acquisition+563SEC filing
2026-05-13HAY LEWIS III · DirectorCommon StockA — Grant, award, or other acquisition+563SEC filing
2026-05-13Schneider Ryan M. · DirectorCommon StockA — Grant, award, or other acquisition+563SEC filing

Showing 8 of 30 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.